blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1996243

EP1996243 - CROSSLINKED GELS COMPRISING POLYALKYLENEIMINES, AND THEIR USES AS MEDICAL DEVICES [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  27.02.2015
Database last updated on 13.11.2024
Most recent event   Tooltip13.10.2017Lapse of the patent in a contracting state
New state(s): HU, TR		published on 15.11.2017  [2017/46]
Applicant(s)For all designated states
HyperBranch Medical Technology, Inc.
800-12 Capitola Drive
Durham, NC 27713 / US
[2014/16]
Former [2013/32]For all designated states
Hyperbranch Medical Technology, Inc.
800-12 Capitola Drive
Durham, NC 27712 / US
Former [2008/49]For all designated states
Hyperbranch Medical Technology, Inc.
801-4 Capitola Drive, Durham
NC 27713 / US
Inventor(s)01 / STOCKMAN, Kenneth, E.
2128 Beneventum Court
Raleigh, NC 27606 / US
02 / CARNAHAN, Michael, A.
1423 Copper Creek Drive
Durham, NC 27713 / US
03 / D'ALESSIO, Keith, R.
305 Jaslie Drive
Carey, NC 27511 / US
04 / GRINSTAFF, Mark, W.
49 Beals Street, Apt. 1
Brookline, MA 02446 / US
 [2008/49]
Representative(s)Crooks, Elizabeth Caroline, et al
Kilburn & Strode LLP
Lacon London
84 Theobalds Road
London WC1X 8NL / GB
[N/P]
Former [2014/17]Crooks, Elizabeth Caroline, et al
Kilburn & Strode LLP 20 Red Lion Street
London WC1R 4PJ / GB
Former [2008/49]Crooks, Elizabeth Caroline, et al
Kilburn & Strode 20 Red Lion Street
London WC1R 4PJ / GB
Application number, filing date07717797.011.01.2007
[2008/49]
WO2007US00819
Priority number, dateUS20060758105P11.01.2006         Original published format: US 758105 P
US20060837199P11.08.2006         Original published format: US 837199 P
[2008/49]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2007082061
Date:19.07.2007
Language:EN
[2007/29]
Type: A2 Application without search report 
No.:EP1996243
Date:03.12.2008
Language:EN
The application published by WIPO in one of the EPO official languages on 19.07.2007 takes the place of the publication of the European patent application.
[2008/49]
Type: B1 Patent specification 
No.:EP1996243
Date:23.04.2014
Language:EN
[2014/17]
Search report(s)International search report - published on:EP18.09.2008
ClassificationIPC:A61L24/04, A61L27/18, A61K31/785, A61K31/787
[2012/52]
CPC:
A61K31/785 (EP,US); A61L26/0019 (US); A61K31/787 (EP,US);
A61L24/0031 (US); A61L24/0036 (US); A61L24/043 (US);
A61L24/046 (EP,US); A61L26/0052 (US); A61L26/008 (US);
A61L26/0085 (US); A61L27/18 (EP,US); A61L27/26 (US);
A61L27/52 (US); A61L27/56 (US); A61B2017/0065 (US);
A61B2017/00951 (US); A61K51/1279 (US); A61L24/00 (US) (-)
C-Set:
A61L24/046, C08L79/02 (EP,US);
A61L27/18, C08L79/02 (US,EP)
Former IPC [2008/49]A61L24/04
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2008/49]
TitleGerman:QUERVERNETZTE GELE MIT POLYALKYLENEIMINE, DEREN VERWENDUNG ALS MEDIZINISCHE GERÄTE[2013/48]
English:CROSSLINKED GELS COMPRISING POLYALKYLENEIMINES, AND THEIR USES AS MEDICAL DEVICES[2008/49]
French:GELS RÉTICULÉS COMPRENANT DES POLYALKYLÈNE-IMINES ET UTILISATION DE CEUX-CI EN TANT QUE DISPOSITIFS MÉDICAUX[2008/49]
Former [2008/49]VERNETZTE GELE MIT POLYALKYLENIMINEN UND IHRE VERWENDUNGEN ALS MEDIZINPRODUKTE
Entry into regional phase10.10.2008National basic fee paid 
10.10.2008Designation fee(s) paid 
10.10.2008Examination fee paid 
Examination procedure17.09.2008Despatch of communication that the application is deemed to be withdrawn, reason: filing fee / search fee not paid in time
25.09.2008Amendment by applicant (claims and/or description)
10.10.2008Examination requested  [2008/49]
18.05.2010Despatch of a communication from the examining division (Time limit: M06)
22.11.2010Reply to a communication from the examining division
22.08.2011Despatch of a communication from the examining division (Time limit: M04)
13.12.2011Reply to a communication from the examining division
28.11.2012Communication of intention to grant the patent
20.03.2013Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
18.06.2013Communication of intention to grant the patent
18.09.2013Fee for grant paid
18.09.2013Fee for publishing/printing paid
15.10.2013Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
14.11.2013Communication of intention to grant the patent
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  18.05.2010
Opposition(s)26.01.2015No opposition filed within time limit [2015/14]
Request for further processing for:The application is deemed to be withdrawn due to non-payment of the filing fee
10.10.2008Request for further processing filed
10.10.2008Full payment received (date of receipt of payment)
Fees paidRenewal fee
30.01.2009Renewal fee patent year 03
13.01.2010Renewal fee patent year 04
14.01.2011Renewal fee patent year 05
11.01.2012Renewal fee patent year 06
10.01.2013Renewal fee patent year 07
21.01.2014Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU11.01.2007
AT23.04.2014
BE23.04.2014
CY23.04.2014
CZ23.04.2014
DK23.04.2014
EE23.04.2014
ES23.04.2014
FI23.04.2014
IT23.04.2014
LT23.04.2014
LV23.04.2014
MC23.04.2014
NL23.04.2014
PL23.04.2014
RO23.04.2014
SE23.04.2014
SI23.04.2014
SK23.04.2014
TR23.04.2014
BG23.07.2014
GR24.07.2014
IS23.08.2014
PT25.08.2014
IE11.01.2015
LU11.01.2015
[2017/39]
Former [2016/07]AT23.04.2014
BE23.04.2014
CY23.04.2014
CZ23.04.2014
DK23.04.2014
EE23.04.2014
ES23.04.2014
FI23.04.2014
IT23.04.2014
LT23.04.2014
LV23.04.2014
MC23.04.2014
NL23.04.2014
PL23.04.2014
RO23.04.2014
SE23.04.2014
SI23.04.2014
SK23.04.2014
BG23.07.2014
GR24.07.2014
IS23.08.2014
PT25.08.2014
IE11.01.2015
LU11.01.2015
Former [2015/43]AT23.04.2014
BE23.04.2014
CY23.04.2014
CZ23.04.2014
DK23.04.2014
EE23.04.2014
ES23.04.2014
FI23.04.2014
IT23.04.2014
LT23.04.2014
LV23.04.2014
MC23.04.2014
NL23.04.2014
PL23.04.2014
RO23.04.2014
SE23.04.2014
SI23.04.2014
SK23.04.2014
BG23.07.2014
GR24.07.2014
IS23.08.2014
PT25.08.2014
LU11.01.2015
Former [2015/39]AT23.04.2014
BE23.04.2014
CY23.04.2014
CZ23.04.2014
DK23.04.2014
EE23.04.2014
ES23.04.2014
FI23.04.2014
IT23.04.2014
LT23.04.2014
LV23.04.2014
NL23.04.2014
PL23.04.2014
RO23.04.2014
SE23.04.2014
SI23.04.2014
SK23.04.2014
BG23.07.2014
GR24.07.2014
IS23.08.2014
PT25.08.2014
LU11.01.2015
Former [2015/36]AT23.04.2014
BE23.04.2014
CY23.04.2014
CZ23.04.2014
DK23.04.2014
EE23.04.2014
ES23.04.2014
FI23.04.2014
IT23.04.2014
LT23.04.2014
LV23.04.2014
NL23.04.2014
PL23.04.2014
RO23.04.2014
SE23.04.2014
SI23.04.2014
SK23.04.2014
BG23.07.2014
GR24.07.2014
IS23.08.2014
PT25.08.2014
Former [2015/18]AT23.04.2014
BE23.04.2014
CY23.04.2014
CZ23.04.2014
DK23.04.2014
EE23.04.2014
ES23.04.2014
FI23.04.2014
IT23.04.2014
LT23.04.2014
LV23.04.2014
NL23.04.2014
PL23.04.2014
RO23.04.2014
SE23.04.2014
SK23.04.2014
BG23.07.2014
GR24.07.2014
IS23.08.2014
PT25.08.2014
Former [2015/11]AT23.04.2014
BE23.04.2014
CY23.04.2014
CZ23.04.2014
DK23.04.2014
EE23.04.2014
ES23.04.2014
FI23.04.2014
LT23.04.2014
LV23.04.2014
NL23.04.2014
PL23.04.2014
RO23.04.2014
SE23.04.2014
SK23.04.2014
BG23.07.2014
GR24.07.2014
IS23.08.2014
PT25.08.2014
Former [2015/10]AT23.04.2014
BE23.04.2014
CY23.04.2014
CZ23.04.2014
DK23.04.2014
EE23.04.2014
ES23.04.2014
FI23.04.2014
LT23.04.2014
LV23.04.2014
NL23.04.2014
PL23.04.2014
SE23.04.2014
SK23.04.2014
BG23.07.2014
GR24.07.2014
IS23.08.2014
PT25.08.2014
Former [2015/08]AT23.04.2014
BE23.04.2014
CY23.04.2014
DK23.04.2014
ES23.04.2014
FI23.04.2014
LT23.04.2014
LV23.04.2014
NL23.04.2014
PL23.04.2014
SE23.04.2014
BG23.07.2014
GR24.07.2014
IS23.08.2014
PT25.08.2014
Former [2015/02]AT23.04.2014
CY23.04.2014
ES23.04.2014
FI23.04.2014
LT23.04.2014
LV23.04.2014
NL23.04.2014
PL23.04.2014
SE23.04.2014
BG23.07.2014
GR24.07.2014
IS23.08.2014
PT25.08.2014
Former [2014/51]AT23.04.2014
CY23.04.2014
ES23.04.2014
FI23.04.2014
LT23.04.2014
LV23.04.2014
NL23.04.2014
PL23.04.2014
SE23.04.2014
BG23.07.2014
GR24.07.2014
IS23.08.2014
Former [2014/50]CY23.04.2014
ES23.04.2014
FI23.04.2014
LT23.04.2014
LV23.04.2014
NL23.04.2014
PL23.04.2014
SE23.04.2014
BG23.07.2014
GR24.07.2014
IS23.08.2014
Former [2014/49]CY23.04.2014
FI23.04.2014
LT23.04.2014
BG23.07.2014
IS23.08.2014
Former [2014/48]CY23.04.2014
LT23.04.2014
BG23.07.2014
Former [2014/47]CY23.04.2014
Cited inInternational search[DA]US4988358  (EPPLEY BARRY L [US], et al) [DA] 1-103* the whole document *;
 [X]US5306504  (LORENZ DONALD H [US]) [X] 1-20,22,24-103 * column 1, line 50 - column 2, line 9 * * column 3, line 1 - line 61 * * examples 1-7 * * claims 1-22 *;
 [X]US5645855  (LORENZ DONALD H [US]) [X] 1-20,22,24-103 * column 1, line 5 - line 15 * * column 1, line 41 - line 46 * * column 2, line 3 - line 52 * * column 3, line 17 - line 61 * * column 4, line 6 - line 17 * * examples 1-9 * * claims 1-26 *;
 [X]EP1120428  (KURARAY CO [JP]) [X] 1-20,22,24-103 * page 2, paragraph 1 * * page 2, paragraph 16 - paragraph 20 * * page 4, paragraph 27 - paragraph 34 * * page 7, paragraph 62 - paragraph 70 * * page 10; example 3 * * page 11; example 5 * * claims 1-10 *;
 [X]US2003035786  (HENDRIKS MARC [NL], et al) [X] 102,103 * page 2, paragraph 14 - paragraph 17 * * page 2, paragraph 21 - page 3, paragraph 25 * * examples 1-3 * * claims 1-35 *;
 [A]  - MOHAMED S ET AL, "PHYSICAL PROPERTIES OF POLYETHYLENEIMINE-ALGINATE GELS", BIOTECHNOLOGY LETTERS, KEW, SURREY, GB, (19820101), vol. 4, no. 9, ISSN 0141-5492, pages 611 - 614, XP009017112 [A] 1-103 * the whole document *

DOI:   http://dx.doi.org/10.1007/BF00127794
by applicant   - HARTMANN, C.; RIECK, P., "A New Test for Endothelial Viability: The Janus Green Photometry Technique", ARCH. OPHTHALMOL., (1989), vol. 107, pages 1511 - 1515
    - PELS, E.; NUYTS, R.M.M.A.; BREEBAART, A,C.; HARTMANN, C., "Rapid Quantitative Assays for Corneal Endothelial Cell Viability", VITRO. CORNEA., (1993), vol. 12, pages 289 - 294
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.